doi: 10.1056/NEJM197810192991605.
Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (third of three parts)
- PMID: 692579
- DOI: 10.1056/NEJM197810192991605
Item in Clipboard
Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (third of three parts)
N Engl J Med.
.
No abstract available
Similar articles
-
Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (second of three parts).N Engl J Med. 1978 Oct 12;299(15):804-11. doi: 10.1056/NEJM197810122991504. N Engl J Med. 1978. PMID: 692564 No abstract available.
-
Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).N Engl J Med. 1978 Oct 5;299(14):752-63. doi: 10.1056/NEJM197810052991405. N Engl J Med. 1978. PMID: 357967 Review. No abstract available.
-
New antisickling agents.Haematologia (Budap). 1983;16(1-4):105-8. Haematologia (Budap). 1983. PMID: 6679483
-
Pathophysiologically based drug treatment of sickle cell disease.Trends Pharmacol Sci. 2006 Apr;27(4):204-10. doi: 10.1016/j.tips.2006.02.007. Epub 2006 Mar 13. Trends Pharmacol Sci. 2006. PMID: 16530854 Review.
-
The increasing complexity of sickle cell anemia.Prog Hematol. 1983;13:25-47. Prog Hematol. 1983. PMID: 6199811 Review. No abstract available.
Cited by
-
Preliminary in vitro antisickilng properties of crude juice extracts of Persia Americana, Citrus sinensis, Carica papaya and Ciklavit®.Afr J Tradit Complement Altern Med. 2009 Dec 30;7(2):113-7. doi: 10.4314/ajtcam.v7i2.50867. Afr J Tradit Complement Altern Med. 2009. PMID: 21304622 Free PMC article.
-
The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects.Br J Clin Pharmacol. 1993 Apr;35(4):419-25. doi: 10.1111/j.1365-2125.1993.tb04160.x. Br J Clin Pharmacol. 1993. PMID: 8485022 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers.Br J Clin Pharmacol. 1995 Apr;39(4):375-80. doi: 10.1111/j.1365-2125.1995.tb04465.x. Br J Clin Pharmacol. 1995. PMID: 7640143 Free PMC article. Clinical Trial.
-
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy.Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6739-6746. doi: 10.1167/iovs.16-19513. Invest Ophthalmol Vis Sci. 2016. PMID: 27951596 Free PMC article.
-
Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.Proc Natl Acad Sci U S A. 1980 May;77(5):2955-9. doi: 10.1073/pnas.77.5.2955. Proc Natl Acad Sci U S A. 1980. PMID: 6930678 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
